A
Avian Influenza
Amoebic Dysentery

C
Chikungunya Fever
Clostridium difficile
Community associated-Methicillin-resistant Staphylococcus aureus (CA-MRSA) Infection
Coronavirus Disease 2019 (COVID-19)
Cryptosporidiosis

D
Dengue Fever

E
Ebola Virus Disease (EVD)
Enterovirus
Escherichia coli

F
Foodborne illness
Food Poisoning

H
Hepatitis
HIV
Human Papillomavirus (HPV)
Human Swine Influenza

I
Infection Control
Influenza

J
Japanese Encephalitis

L
Legionnaires' Disease
Listeriosis

M
Malaria
Measles
Meningococcal Infection
Middle East Respiratory Syndrome
Mpox

N
Norovirus

O
Outbreak Control and Investigation

P
Pertussis
Plague
Pneumococcus
Poliovirus

R
Rabies
Respiratory Syncytial Virus Infection

S
Severe Fever with Thrombocytopenia Syndrome
Shiga toxin-producing Escherichia coli Infection 

T
Tuberculosis

V
Vector-borne Diseases
Varicella (Chickenpox)

Y
Yellow Fever

Z
Zika Virus

Avian Influenza

• Recommendation on Control of the Risk of Transmission of Avian Influenza to Humans in the Long Term (July 2016)
• Summary of Recommendations on Management of Close Contacts of Cases of Human Infection with Avian Influenza in Hong Kong (March 2015)
• Consensus Summary on Avian Influenza A (H7N9) (October 2014)
• Consensus Summary on Avian Influenza A (H7N9) (March 2014)
• Avian Influenza Situation Updates (December 2007)
• Suspension Period of Live Poultry Supply from the Mainland (August 2006)
• Recommendations To Reduce Risk of H5N1 Avian Influenza Infection (February 2006)
• Latest Development in Avian Influenza (December 2005)
• Avian influenza H5N1: Assessing the current risk of human-to-human transmission (March 2005)
• Avian Influenza (H5N1) in Southeast Asia Region (November 2004)

Amoebic Dysentery

• Prevention and Control of Amoebic Dysentery in Hong Kong (April 2014)

Chikungunya Fever

• Epidemiology, Prevention and Control of Chikungunya Fever (August 2025)
• Consensus Statement on the Prevention and Control of Chikungunya Fever in Hong Kong (August 2025)

Clostridium difficile

• Epidemiology, Prevention and Control of Clostridium difficile associated outbreaks in Hong Kong (August 2014)

Community associated-Methicillin-resistant Staphylococcus aureus (CA-MRSA) Infection

• Summary of Recommendations for Prevention and Control of Community-Associated Methicillin-Resistant Staphylococcus aureus in Hong Kong (May 2017)

Coronavirus Disease 2019 (COVID-19)

• Consensus Recommendations on the Use of COVID-19 Vaccines in Hong Kong (As of 20 October 2025)

• Consensus Interim Recommendations on Use of COVID-19 Vaccines in Hong Kong (As of 17 July 2024)

• Consensus Interim Recommendations on the Use of COVID-19 Vaccines in Hong Kong (As of 20 February 2024)
• Consensus Interim Recommendations on the Use of COVID-19 Vaccines in Hong Kong (As of 11 October 2023)

• Consensus Interim Recommendations on the Use of COVID-19 Vaccines in Hong Kong (As of 6 June 2023)

• Consensus Interim Recommendations on the Use of COVID-19 Vaccines in Hong Kong (As of 29 March 2023)
• Consensus Interim Recommendations on the Use of COVID-19 Vaccines in Hong Kong (As of 1 December 2022)

• Consensus Interim Recommendations on the Use of COVID-19 Vaccines in Hong Kong (As of 13 October 2022)

• Consensus Interim Recommendations on Co-administration of COVID-19 vaccine with other vaccines in Hong Kong (As of 11 August 2022)

• Consensus Interim Recommendations on the Use of COVID-19 Vaccines in Hong Kong (As of 1 August 2022)

• Consensus Interim Recommendations on the Use of Comirnaty COVID-19 Vaccines in Hong Kong (As of 16 June 2022)
• Consensus Interim Recommendations on the Use of COVID-19 Vaccines in Hong Kong (As of 19 May 2022)

• Consensus Interim Recommendations on the Use of COVID-19 Vaccines in Hong Kong (As of 6 April 2022)
• Consensus Interim Recommendations on the Use of COVID-19 Vaccines in Persons with Previous COVID-19 Infection and Children in Hong Kong (As of 12 March 2022)
• Consensus Interim Recommendations on the Use of COVID-19 Vaccines in Hong Kong (As of 25 February 2022)(Updated on 12 Mar 2022)
• Consensus Interim Recommendations on the Use of COVID-19 Vaccines in Children in Hong Kong (As of 17 January 2022)

• Consensus Interim Recommendations on the Use of Comirnaty Vaccine in Hong Kong (As of 23 December 2021)
• Consensus Interim Recommendations on the Use of CoronaVac vaccine in children and adolescents in Hong Kong (As of 19 November 2021)
• Consensus Interim Recommendations on the Use of COVID-19 Vaccines in Hong Kong (As of 27 October 2021)(Updated on 19 November 2021)
• Consensus Interim Recommendations on the Use of COVID-19 Vaccines in Hong Kong (As of 15 September 2021)

• Updated Consensus Interim Recommendations on the Quarantine requirements for Vaccinated Inbound Travellers (As of 16 August 2021)
• Updated Consensus Recommendations on Criteria for Releasing Confirmed COVID-19 Patients from Isolation (As of 4 August 2021) 
• Consensus Interim Recommendations on the Use of COVID-19 Vaccines in Hong Kong (As of 22 July 2021)
• Consensus Interim Recommendations on the Use of COVID-19 Vaccines in Hong Kong (As of 9 June 2021)

• Consensus Interim Recommendations on the Quarantine requirements for Vaccinated Inbound Travellers (As of 9 June 2021)
• Updated Consensus Interim Recommendations on the Quarantine requirements for Vaccinated Close Contacts of Locally acquired cases of COVID-19 (As of 9 June 2021)
• Updated Consensus Interim Recommendations on the Quarantine requirements for Vaccinated Close Contacts of Locally acquired cases of COVID-19 (As of 13 May 2021)
• Consensus Interim Recommendations on the Quarantine requirements for Vaccinated Close Contacts of Locally acquired cases of COVID-19 (As of 6 May 2021)
• Consensus Interim Recommendations on the Use of COVID-19 Vaccines in Hong Kong (As of 6 May 2021)

• Consensus Interim Recommendations on the Use of COVID-19 Vaccines in Hong Kong (As of April 22 2021)
• Consensus Interim Recommendations on the Use of COVID-19 Vaccines in Hong Kong (As of March 18 2021)
• Consensus Interim Recommendations on the Use of CoronaVac in Hong Kong (As of February 19 2021)(Updated on 19 Nov 2021)

• Consensus on the Use of BNT162b2 among Frail Elderly in Hong Kong (As of 8 February 2021)
• Consensus Interim Recommendations on the Use of COVID-19 Vaccines in Hong Kong (As of Jan 7 2021)
• Recommendations on prevention and control of novel coronavirus infection made during the joint meeting held on February 17, 2020 (Feb 2020)
• Recommendations on prevention and control of novel coronavirus infection made during the joint meeting held on January 24, 2020 (Jan 2020)

Cryptosporidiosis

• Epidemiology, Prevention and Control of Cryptosporidiosis in Hong Kong (November 2019)

Dengue Fever

• Update on Epidemiology, Prevention and Control of Dengue Fever in Hong Kong (April 2016)
• Updated Consensus Summary of Recommendations on Prevention and Control of Dengue Fever in Hong Kong (June 2015)
• Consensus Summary of Recommendations on Prevention and Control of Dengue Fever in Hong Kong (December 2014)

Link to Japanese Encephalitis, Malaria, Mosquito Control

Ebola Virus Disease (EVD)

• Recommendations on Use of Personal Protective Equipment (PPE) in the setting of Ebola Virus Disease (EVD) in Hong Kong (December 2014)
• Consensus Summary on Ebola Virus Disease (EVD) (October 2014)
• Consensus Summary on Ebola Virus Disease (EVD) (August 2014)

Enterovirus

• Update on Situation of Enterovirus Infection (May 2015)

Escherichia coli

• Epidemiology, Prevention and Control of Shiga toxin-producing Escherichia coli Infection (December 2023)

Foodborne illness

• Situation of Enteric Infection and Foodborne Diseases in Hong Kong (2012 - 2021) (February 2023)

Food Poisoning

• Review on the Global and Local Epidemiology of Food Poisoning (December 2017)
• Tetrodotoxin Poisoning in Hong Kong (May 2015)

Hepatitis

• Epidemiology, Prevention and Control of Human Infection of Rat Hepatitis E Virus in Hong Kong (September 2023)
• Recommendations on STI Testing for MSM in Hong Kong (November 2020)

• Recommendations on Prevention of Healthcare-associated Transmission of Hepatits C Virus during Blood Sampling (April 2018)
• Statement on Hepatitis A Vaccination and Men who have Sex with Men (June 2017)
• Review on the Epidemiology and Prevention and Control of Hepatitis A (Jan 2016)
• Recommendation on the Management of Human Immunodeficiency Virus and Hepatitis B Coinfection (October 2008)
• Recommendations on the Management and Postexposure Prophylaxis of Needlestick Injury or Mucosal Contact to HBV, HCV and HIV (January 2014)
• Hepatitis A immunisation in high risk groups and outbreak situations (July 2006)

HIV

• Recommendations on STI Testing for MSM in Hong Kong (November 2020)
• Recommendations on the Management of Human Immunodeficiency Virus and Tuberculosis Coinfection (November 2020)
• Recommended Clinical Guidelines on the Prevention of Perinatal HIV Transmission (November 2018)
• Recommendations on the Use of Non-occupational Post-exposure Prophylaxis against HIV (November 2018)
• Interim Statement on HIV Pre-exposure Prophylaxis (PrEP) (December 2016)
• Recommended Principles and Practice of HIV Clinical Care in Hong Kong (August 2016)
• Recommendations on the Management and Postexposure Prophylaxis of Needlestick Injury or Mucosal Contact to HBV, HCV and HIV (January 2014)
• Principles of Consent, Discussion and Confidentiality Required of the Diagnostic HIV Test (July 2011)
• Recommended Principles of Antiretroviral Therapy in HIV Disease (February 2011)
• The Use of BCG Vaccine in HIV Infected Patients (November 2009)
• Recommendation on the Management of Human Immunodeficiency Virus and Hepatitis B Coinfection (October 2008)
• Recommendations on Infection Control Practice for HIV Transmission in Health Care Settings (January 2005)

Human Papillomavirus (HPV)

• Updated Recommendations on the Use of Human Papillomavirus Vaccine in Hong Kong (As of 30 November 2022)
• Joint Consensus Recommendation on the Use of 9-valent Human Papillomavirus Vaccine in Prevention of Cervical Cancer in Hong Kong (September 2018)
• Consensus Statement on the Use of Human Papillomavirus (HPV) Vaccine in Prevention of Cervical Cancer (September 2016)

Human Swine Influenza

• Recommendations on Human Swine Influenza (HSI) Vaccination (January 2010)

Infection Control

• Infection Control Corner
• Recommendations on Prevention of Ventilator-associated Pneumonia (November 2018)
• Recommendations on Surgical Site Infection Surveillance (November 2018)
• Recommendations on Prevention of Healthcare-associated Transmission of Bloodborne Viruses during Blood Sampling (July 2018)
• Recommendations on Prevention of Healthcare-associated Transmission of Hepatits C Virus during Blood Sampling (April 2018)
• Recommendations on Hand Hygiene and Use of Gloves in Health Care Settings (November 2017)

• Recommendations on Prevention of Catheter-associated Urinary Tract Infection (March 2017)
• Recommendations on Prevalence Survey of Hospital Acquired Infections (February 2006)
• Recommendations on Hospital Infection Control System in Hong Kong (January 2005)

Influenza

• Recommendations on Seasonal Influenza Vaccination For the 2025-26 Season in Hong Kong (As of 21 March 2025)
• Recommendations on Seasonal Influenza Vaccination for the 2024-25 Season (March 2024)
• Recommendations on Seasonal Influenza Vaccination for the 2023-24 Season (April 2023)

• Recommendations on Seasonal Influenza Vaccination for the 2022-23 Season (October 2022)

• Recommendations on Seasonal Influenza Vaccination for the 2022-23 Season (April 2022)
• Recommendations on Seasonal Influenza Vaccination for the 2021-22 Season (April 2021)
• Recommendations on Seasonal Influenza Vaccination for the 2020/21 Season (May 2020)
• Recommendations on Seasonal Influenza Vaccination for the 2019/20 Season (April 2019)
• Consensus Statement on Dosing Schedule of SIV for Children Aged 6 Months to 8 Years in 2018-19 Season (October 2018)
• Consensus Recommendation on School Closure due to Seasonal Influenza (August 2018)
• Recommendations on Seasonal Influenza Vaccination for the 2018/19 Season (April 2018)
• Interim Consensus Statement on Use of Seasonal Influenza Vaccine in Hong Kong in Remaining Period of 2017/18 Season (February 2018)
• Recommendations on Seasonal Influenza Vaccination for the 2017/18 Season (June 2017)
• Recommendations on Seasonal Influenza Vaccination for the 2016/17 Season (June 2016)
• Recommendations on Seasonal Influenza Vaccination for the 2015/16 Season (July 2015)
• Summary of Recommendations on Antiviral Stockpiling for Influenza Pandemics (October 2014)
• Recommendations on Seasonal Influenza Vaccination for the 2014/15 Season (July 2014)
• Interim Recommendations on Seasonal Influenza Vaccination for the 2014/15 Season (April 2014)
• Recommendations on Seasonal Influenza Vaccination for the 2013/14 Season (July 2013)
• Recommendations on Seasonal Influenza Vaccination for the 2012/13 Season (Updated in May 2013)
• Recommendations on Seasonal Influenza Vaccination for the 2011/12 Season (June 2011)
• Recommendations on Seasonal Influenza Vaccination for the 2010/11 Season (August 2010)
• Recommendations on Seasonal Influenza Vaccination for the 2009/10 Season (July 2009)
• Recommendations on Influenza Vaccination for the 2008/09 Season (June 2008)
• General guide to doctors: antiviral use for novel influenza treatment and prophylaxis (December 2007)
• Statements on Influenza Vaccination for the 2007/08 Season (May 2007)
• Statements on Influenza Vaccination for the 2006/07 Season (April 2006)
• Statement from the Working Group on Influenza Vaccination (December 2005)
• Statements on Influenza Vaccination for the 2005/06 Season(August 2005)
• Statements on Influenza Vaccination for the 2004/05 Season(September 2004)

Japanese Encephalitis

• Scientific Committee on Vaccine Preventable Diseases and Scientific Committee on Vector-borne Diseases Updated Recommendation on Japanese Encephalitis Vaccination (November 2016)
• Update on epidemiology, prevention and control of Japanese encephalitis in Hong Kong (July 2014)
• Scientific Committee on Vaccine Preventable Diseases and Scientific Committee on Vector-borne Diseases Updated Recommendation on Japanese Encephalitis Vaccination for Travellers to Endemic Areas (July 2011)  

Legionnaires' Disease

• Consensus Summary of Recommended Strategy for Prevention and Control of Legionnaires' Disease in Hong Kong (December 2015)

Listeriosis

• Update on Epidemiology of Listeriosis in Hong Kong (August 2018) 

Malaria

• Global Malaria Risk Summary (August 2024)
• Global Malaria Risk Summary (May 2022)
• Global Malaria Risk Summary (October 2019)
• Guidelines on Malaria Chemoprophylaxis for Travellers from Hong Kong (April 2018)

• Global Malaria Risk Summary October 2017 (October 2017)
• Global Malaria Risk Summary February 2016 (November 2016)
• Global Malaria Risk Summary October 2014 (October 2014)

Measles

• Guiding Principles for Measles Vaccination for Non-immune Adults in Hong Kong (June 2019)
• Recommendation on the Schedule of the Second Dose of Measles-containing Vaccine in Hong Kong (November 2018)

Meningococcal Infection

• Updated Recommendations on the Use of Meningococcal Vaccines in Hong Kong (As of 28 July 2025)
• Recommendation for use and advice for travellers on use of Meningococcal vaccines (June 2005)

Middle East Respiratory Syndrome

• Consensus Summary on Middle East Respiratory Syndrome (October 2014)
• Consensus Summary on Middle East Respiratory Syndrome (March 2014)

Mpox

• Consensus Interim Recommendations on the Use of Monkeypox Vaccines in Hong Kong (As of 15 September 2022)

• Consensus Interim Recommendations on the Use of Monkeypox Vaccines in Hong Kong (As of 16 June 2022)

Norovirus

• Update on Acute Viral Gastroenteritis Outbreaks in Hong Kong (November 2024)
• Update on Norovirus-associated Acute Gastroenteritis Outbreaks in Hong Kong (August 2018)

Outbreak Control and Investigation

• Recommendations on Laboratory Testing in Outbreak Investigation (March 2018)

Pertussis

• Consensus Recommendations on Pertussis Vaccination for Pregnant Women in Hong Kong (February 2019)
• Recommendations on updated childhood immunisation programme containing inactivated poliovirus and acellular pertussis vaccines (December 2006)

Plague

• Situation of Plague and Prevention Strategies (November 2008)

Pneumococcus

• Updated Recommendations on the Use of 13-valent Pneumococcal Conjugate Vaccine in Childhood Immunisation Programme (March 2019)
• Recommendations on the use of 15-valent Pneumococcal Conjugate Vaccine (PCV15) and 20-valent Pneumococcal Conjugate Vaccine (PCV20) in Hong Kong (As of 27 September 2023)
• Updated Recommendations on the Use of Pneumococcal Vaccines for High-risk Individuals (July 2016)
• Updated Recommendations on the Use of Pneumococcal Vaccines for High-risk Individuals (December 2014)
• Recommendations on the Use of 13-valent Pneumococcal Conjugate Vaccine in Childhood Immunisation Programme (April 2011)
• Recommendations on the Interchangeability between 7-valent Pneumococcal Conjugate Vaccine (PCV7) and 10-valent Pneumococcal Conjugate Vaccine (PCV10) (August 2010)
• Recommendations on the Use of Pneumococcal Vaccines (March 2009)
• Use of Hepta-valent Pneumococcal Conjugate Vaccine in the Childhood Immunisation Programme (October 2008)

Poliovirus

• Recommendations on updated childhood immunisation programme containing inactivated poliovirus and acellular pertussis vaccines (December 2006)

Rabies

• Prevention and Control of Rabies (June 2005)

Respiratory Syncytial Virus Infection

• Interim Consensus on the Use of Respiratory Syncytial Virus Vaccines in Hong Kong (As of 17 January 2025)

Severe Fever with Thrombocytopenia Syndrome

• Epidemiology, Prevention and Control of Severe Fever with Thrombocytopenia Syndrome (August 2024)

Shiga toxin-producing Escherichia coli Infection

• Epidemiology, Prevention and Control of Shiga toxin-producing Escherichia coli Infection (December 2023)

Tuberculosis

• Recommendations on the Management of Human Immunodeficiency Virus and Tuberculosis Coinfection (November 2020)
• The Use of BCG Vaccine in HIV Infected Patients (November 2009)

Vector-borne Diseases

• Proposed Work Plan for the Scientific Committee on Vector-borne Diseases (SCVBD) (August 2004)

Varicella (Chickenpox)

• Recommendations on the Use of Varicella (Chickenpox) Vaccine in Childhood Immunisation Programme (February 2013)

Yellow Fever

• Update on epidemiology, prevention and control of yellow fever (June 2017)

Zika Virus

• Consensus Statement on Prevention and Control of Zika Virus Infection (August 2018)
• Consensus Statement on Prevention and Control of Zika Virus Infection (October 2016)
• Consensus Summary on Prevention and Control of Zika Virus Infection (April 2016)
• Consensus Summary on Prevention and Control of Zika Virus Infection (February 2016)